Silver Book Fact

Delaying the onset of Alzheimer’s by only 5 years could reduce the number of people with Alzheimer’s by almost 50% after 50 years.

Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset. Am J Public Health. 1998; 88(9): 1337-42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1509089/

Reference

Title
Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset
Publication
Am J Public Health
Publication Date
1998
Authors
Brookmeyer R, Gray S, Kawas C
Volume & Issue
Volume 88, Issue 9
Pages
1337-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The U.S. Food and Drug Administration has approved 5 drugs that have proven to temporarily slow the worsening of Alzheimer’s disease symptoms for an average of 6 – 12 months…  
  • Galantamine, a cholinesterase inhibitor, delays Alzheimer’s patients’ need for full-time care, with overall cost savings estimated between $323 and $4,256 per patient.  
  • Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.  
  • An Alzheimer’s treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce out-of-pocket costs to people with the disease by $25 billion in 2050–from the…  
  • A treatment that delayed the age of onset of Alzheimer’s disease by five years would reduce the proportion of Americans age 65 and older with the disease from 10% to…